The effect of treatment recurrent Herpes simplex with larifan

E Niedrite; I Mikazans; G Feldmane; A Volrate

The effect of treatment recurrent Herpes simplex with larifan

E Niedrite, I Mikazans, G Feldmane, A Volrate

Department of Dermatology and Venereology

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S74-S74
Number of pages	1
Journal	Clinical Immunology
Volume	115
Publication status	Published - 2005
Event	5th Annual Meeting of the Federation of Clinical Immunology Societies - Boston, United States Duration: 12 May 2005 → 16 May 2005 Conference number: 5 https://www.unboundmedicine.com/medline/citation/15957212/Abstracts_of_the_5th_Annual_Meeting_of_the_Federation_of_Clinical_Immunology_Societies__Boston_Massachusetts_USA__May_12_16_2005_

Field of Science*

3.2 Clinical medicine

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this

@article{4b5a01e7b72e4eeb81bdd403b4f85a4d,

title = "The effect of treatment recurrent Herpes simplex with larifan",

author = "E Niedrite and I Mikazans and G Feldmane and A Volrate",

year = "2005",

language = "English",

volume = "115",

pages = "S74--S74",

journal = "Clinical Immunology",

issn = "1521-6616",

publisher = "Academic Press Inc.",

note = "5th Annual Meeting of the Federation of Clinical Immunology Societies ; Conference date: 12-05-2005 Through 16-05-2005",

url = "https://www.unboundmedicine.com/medline/citation/15957212/Abstracts\_of\_the\_5th\_Annual\_Meeting\_of\_the\_Federation\_of\_Clinical\_Immunology\_Societies\_\_Boston\_Massachusetts\_USA\_\_May\_12\_16\_2005\_",

}

TY - JOUR

T1 - The effect of treatment recurrent Herpes simplex with larifan

AU - Niedrite, E

AU - Mikazans, I

AU - Feldmane, G

AU - Volrate, A

N1 - Conference code: 5

PY - 2005

Y1 - 2005

M3 - Meeting Abstract

SN - 1521-6616

VL - 115

SP - S74-S74

JO - Clinical Immunology

JF - Clinical Immunology

T2 - 5th Annual Meeting of the Federation of Clinical Immunology Societies

Y2 - 12 May 2005 through 16 May 2005

ER -